Study on the Safety and Immune Response of GSK's Herpes Zoster Vaccine in Immunocompromised Children Aged 1-17 with Kidney Transplants
- Substances:GSKVX000000014593
France- Participants:0–17 years
- Substances:GSKVX000000014593
Rare diseases
Investigational molecules
Locations
FranceStudy on Botensilimab Alone and with Balstilimab or Drug Combination for Patients with Refractory Metastatic Colorectal Cancer
FranceLong-Term Safety Study of Venetoclax for Patients with Chronic Lymphocytic Leukemia, Non-Hodgkin's Lymphoma, Multiple Myeloma, or Acute Leukemia
FranceStudy on UCART20x22 for Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma Using a Drug Combination
France
FranceStudy on Selexipag and Bosentan for Children with Pulmonary Arterial Hypertension
FranceStudy of Pembrolizumab in Patients with Esophageal Cancer Undergoing Chemoradiotherapy
FranceStudy on Imlifidase and Drug Combination for Treating Severe Goodpasture Disease in Patients
FranceStudy on the Effectiveness of High-Dose Vitamin C for Patients with Shock After Cardiac Arrest
FranceStudy on Surgery with or without Darolutamide for Patients with High-Risk or Locally Advanced Prostate Cancer
FranceStudy Comparing Bictegravir and Lenacapavir to Current Treatment in Patients with HIV-1 on Complex Regimens
FranceStudy on Long-term Safety of Ustekinumab for Children with Crohn's Disease, Juvenile Psoriatic Arthritis, or Ulcerative Colitis
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.